Audit 401301

FY End
2025-12-31
Total Expended
$1.06M
Findings
0
Programs
8
Organization: Denver Research Institute, Inc. (CO)
Year: 2025 Accepted: 2026-05-13

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.866 AGING RESEARCH $164,622 Yes 0
93.837 CARDIOVASCULAR DISEASES RESEARCH $80,908 Yes 0
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $51,537 Yes 0
93.393 CANCER CAUSE AND PREVENTION RESEARCH $41,316 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $21,016 Yes 0
93.399 CANCER CONTROL $13,767 Yes 0
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $2,275 Yes 0
93.395 CANCER TREATMENT RESEARCH $96 Yes 0

Contacts

Name Title Type
JPCLGB7EJXG3 Cynthia Gasaway Auditee
3035010540 Amanda Good Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal grant activity of the Denver Research Institute (the Organization) under programs of the federal government for the year ended December 31, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Organization, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Organization.